Report #2857601

Received Sep 9, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 64 yrs
State: TX
Recovered: Recovered
Vaccinated: Aug 29, 2025
Onset: Aug 31, 2025
Days to onset: 2
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
UNK	VACCINE NOT SPECIFIED (OTHER)	UNKNOWN MANUFACTURER	1	—	IM / LA

Symptoms (5)

Influenza like illnessInjection site erythemaInjection site painInjection site swellingPost inflammatory pigmentation change

Symptom narrative

PCV 21 polysaccharide CRM197 Conjugate, PF Manufacturer: Merck & Co Lot: Z006889 Exp: 9/9/2026; Patient reports flu-like symptoms later in evening, same day of vaccination, however developed site pain, redness, swelling Sunday. Concern for severe delayed site reaction, possible superimposed cellulitis and patient was recommended to trial supportive care with ice compress, Benadryl, and 7 day course of keflex 500mg TID with resolution of symptoms 2-3 days later. Residual post inflammatory hyperpigmentation remains

Medical history

Schizoaffective disorder, anxiety, and osteopenia, prediabetes

Other medications

? Calcium Carbonate-Vit D-Min (CALTRATE PLUS PO) ? chlordiazePOXIDE (Librium) 10 MG capsule ? cloZAPine (Clozaril) 25 MG tablet ? coenzyme Q-10 200 MG capsule ? DULoxetine (Cymbalta) 20 MG DR capsule ? Magnesium Citrate 100 MG ta

Allergies

Fluphenazine